Trials / Sponsors / AskBio Inc
AskBio Inc
Industry · 9 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Prescriptive Infusion Algorithm (PIA) PARKINSON DISEASE (Disorder) | Phase 2 | 2026-05-01 |
| Recruiting | A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participant Pompe Disease (Late-onset), Pompe Disease Late-Onset, LOPD | Phase 1 / Phase 2 | 2026-02-10 |
| Enrolling By Invitation | AB-1005 Long-Term Follow-up Study Parkinson's Disease, Multiple System Atrophy, Parkinson Variant | — | 2025-09-04 |
| Recruiting | A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) Parkinson Disease | Phase 2 | 2024-06-11 |
| Active Not Recruiting | Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failur Congestive Heart Failure | Phase 2 | 2023-10-20 |
| Recruiting | A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2 Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2, LGMD2I | Phase 1 / Phase 2 | 2023-05-15 |
| Active Not Recruiting | Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy Parkinson's Disease, Multiple System Atrophy, Parkinson Variant, Multiple System Atrophy | — | 2022-09-29 |
| Active Not Recruiting | AB-1002 in Patients With Class III Heart Failure Congestive Heart Failure, Heart Failure, Heart Disease, Ischemic | Phase 1 | 2019-11-20 |
| Completed | AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease Pompe Disease | Phase 1 | 2018-12-17 |